Ulrike Graefe‐Mody

A reference map of potential determinants for the human serum metabolome

Noam Bar, Tal Korem, Omer Weissbrod et al. · Nature · 2020 · 427 citations · Full text

Reference Map, Human Serum Metabolome, Medicine +11

Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase‐4 inhibitor linagliptin ^*

Ulrike Graefe‐Mody, Christian Friedrich, Andreas Port et al. · Diabetes Obesity and Metabolism · 2011 · 185 citations

Linagliptin (BI 1356), a potent and selective DPP‐4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes

Thomas Först, B. Uhlig‐Laske, Arne Ring et al. · Diabetic Medicine · 2010 · 128 citations

Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models

Rosa Lundbye Allesøe, Agnete Troen Lundgaard, Ricardo Hernández Medina et al. · Nature Biotechnology · 2023 · 95 citations · Full text

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

Adem Y. Dawed, Andrea Mari, Andrew Brown et al. · The Lancet Diabetes & Endocrinology · 2022 · 92 citations · Full text